Neuroleptics Flashcards
Chlorpromazine (Thorazine)
C: First-generation antipsychotics (phenothiazine)
M: Catalepsy (trance, muscle rigidity, lack of voluntary movement)
T: Schizophrenia (hallucinations, delusions), movement disorder in Huntingtons
SE: NMS** Extrapyramidal, tardive dyskinesia; sedation, postural hypotension, weight gain, anticholinergic effects; sexual dysfunction, hyperprolactinemia
MISC: Little effect on negative symptoms
Fluphenazine (Prolixin)
C: First-generation antipsychotics (phenothiazine)
M: Catalepsy (trance, muscle rigidity, lack of voluntary movement)
T: Schizophrenia (hallucinations, delusions), movement disorder in Huntingtons
SE: NMS** Extrapyramidal (more than chlorpromazine), tardive dyskinesia; sedation (less than chlorpromazine), hypotension, anticholinergic effects; sexual dysfunction, hyperprolactinemia
MISC: Little effect on negative symptoms
Trifluoperazine (Stelazine)
C: First-generation antipsychotics (phenothiazine)
M: Catalepsy (trance, muscle rigidity, lack of voluntary movement)
T: Schizophrenia (hallucinations, delusions)
SE: NMS** Extrapyramidal, tardive dyskinesia; sexual dysfunction, hyperprolactinemia
MISC: Little effect on negative symptoms
Perphenazine (Trilafon)
C: First-generation antipsychotics (phenothiazine)
M: Catalepsy (trance, muscle rigidity, lack of voluntary movement)
T: Schizophrenia (hallucinations, delusions)
SE: NMS** Extrapyramidal (less than chlorpromazine), tardive dyskinesia; sedation (less than chlorpromazine); sexual dysfunction, hyperprolactinemia
MISC: Little effect on negative symptoms
Thioridazine (Mellaril)
C: First-generation antipsychotics (phenothiazine)
M: Catalepsy (trance, muscle rigidity, lack of voluntary movement)
T: Schizophrenia (hallucinations, delusions)
SE: NMS** Extrapyramidal, tardive dyskinesia; sexual dysfunction, hyperprolactinemia
MISC: Little effect on negative symptoms
Thiothixene (Navane)
C: First-generation antipsychotics (thioxanthine)
M: Catalepsy (trance, muscle rigidity, lack of voluntary movement)
T: Schizophrenia (hallucinations, delusions)
SE: NMS** Extrapyramidal, tardive dyskinesia; sexual dysfunction, hyperprolactinemia
MISC: Little effect on negative symptoms
Loxapine (Loxitane)
C: First-generation antipsychotics (dibenzoxazepine)
M: Catalepsy (trance, muscle rigidity, lack of voluntary movement)
T: Schizophrenia (hallucinations, delusions)
SE: NMS** Extrapyramidal (less than chlorpromazine), tardive dyskinesia; sedation (less than chlorpromazine); sexual dysfunction, hyperprolactinemia
MISC: Little effect on negative symptoms
Haloperidol (Haldol)
C: First-generation antipsychotics (butyrophenone)
M: Catalepsy (trance, muscle rigidity, lack of voluntary movement)
T: Schizophrenia (hallucinations, delusions); severe Huntington’s movement disorders (low dose)
SE: NMS** Extrapyramidal (more than chlorpromazine), tardive dyskinesia; sedation (less than chlorpromazine), hypotension, anticholinergic effects; sexual dysfunction, hyperprolactinemia
MISC: Little effect on negative symptoms
Tetrabenazine (Xenazine)
C: -- M: Dopamine-depleting, VMAT2 inhibitor T: Movement disorder in Huntingtons; tardive dyskinesia SE: NMS** MISC:--
Dantrolene (Dantrium)
C:-- M: Muscle relaxant T: Malignant hyperthermia (associated with NMS) SE: -- MISC: --
Clozapine (Clozaril)
C: Second-Generation Antipsychotics (tricyclic)
M: D2 receptor antagonist, 5HT2 receptor antagonist
T: Treatment-resistant psychoses (including schizophrenia); decreases risk of suicide; can be used in pregnancy
SE: Agranulocytosis; weight gain, type II DM, seizure risk, hyperlipidemia** Akathesia (rare, at high doses); GI hypomotility; myocarditis
MISC: No catalepsy, no EPS, no TD
Olanzapine (Zyprexa)
C: Second-Generation Antipsychotics (tricyclic)
M: D2 receptor antagonist, 5HT2 receptor antagonist
T: Schizophrenia (effective against positive symptoms, modest effect on negative); severe bilpolar
SE: Metabolic complications (weight gain, hyperglycemia, type 2 DM, hyperlipidemia)** Somnolence, dizziness, increased serum hepatic transaminases, postural hypotension, constipation; EPS, hyperprolactinemia, akathesia may occur
MISC: –
Quetiapine (Seroquel)
C: Second-Generation Antipsychotics (tricyclic)
M: D2 receptor antagonist, 5HT2 receptor antagonist
T: Schizophrenia (effective against positive symptoms, modest effect on negative)
SE: Weight gain, hyperglycemia, postural hypotension, constipation, somnolence, dizziness**
MISC: –
Risperidone (Risperdal)
C: Second-Generation Antipsychotics (non-tricyclic)
M: D2 receptor antagonist, 5HT2 receptor antagonist
T: Schizophrenia (effective against positive symptoms, modest effect on negative); severe bilpolar
SE: Weight gain, hyperglycemia, postural hypotension, constipation, insomnia, dizziness, hyperprolactinemia; EPS at greater doses**
MISC: Fewer metabolic complications compared to tricyclics, but highest EPS in 2GA
Ziprazidone (Geodon)
C: Second-Generation Antipsychotics (non-tricyclic)
M: D2 receptor antagonist, 5HT2 receptor antagonist
T: Schizophrenia (effective against positive symptoms, modest effect on negative)
SE: Somnolence, cardiac arrhythmias (QTc prolongation); EPS in 5%**
MISC: Fewer metabolic complications compared to tricyclics